1 year return (CAGR)
-33.25%
Medicenna Therapeutics Corp Exchange (NASDAQ, USD)
MDNA
-
-0.01 (-2.95%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-60.34%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
21.29M
Price/Sales
-
Ent value
-92.81K
Price/Book
0.91
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.31 |
| Daily high | 0.31 |
| Daily low | 0.30 |
| Daily Volume | 50K |
| 1y analyst estimate | 2.75 |
| Beta | 0.77 |
| EPS (TTM) | -0.20 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| MDNA | S&P500 | |
| Current price drop from All-time high | -94.88% | -1.87% |
| Highest price drop | -97.37% | -56.47% |
| Date of highest drop | 1 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -58.41% | -10.68% |
| Avg time to new high | 78 days | 12 days |
| Max time to new high | 759 days | 1805 days |
News
No items found